The European Brain Council (EBC) is pleased to announce its endorsement of the “European Migraine and Headache Alliance (EMHA) Roadmap 2025”, a major new initiative to advance migraine awareness, research, and policy at the European level.

Migraine is a complex and disabling neurological condition affecting more than 41 million adults across the EU, and remains one of the most common, yet frequently misunderstood, health issues of our time. Despite its profound impact on well-being, productivity, and gender equity, migraine continues to be underestimated in both clinical and policy arenas, leaving many patients without sufficient support or access to effective treatment.​

The EMHA Roadmap 2025, presented during the “Breaking the Silence on Migraine” event at the European Parliament, sets out concrete strategic aims and policy recommendations, including:

  • Prioritising the development of a dedicated EU Neurological Health Strategy and the formal recognition of migraine within EU and Member State health frameworks

  • Recognising migraine as a key women’s health and economic issue, ensuring fair access to treatments and removing unnecessary barriers to innovative care

  • Supporting coordinated EU action through research investment, GP training, public awareness campaigns, and the creation of a pan-European platform for exchanging best practice

By bringing together the voices of patients, clinicians, advocates, and policy-makers, the Roadmap paves the way for more integrated, evidence-based, and compassionate migraine care throughout Europe.

EBC wholeheartedly supports these efforts and calls on stakeholders in healthcare, research, and policy to endorse and implement the recommendations of the EMHA Roadmap. Together, we can ensure that migraine is no longer a silent burden, but a recognised priority in European brain health strategies, improving quality of life and mitigating both the economic and social impacts for millions across the continent.

Read more about the EMHA Roadmap 2025 and join us in leading the change for healthier brains in Europe.